Top rated lung cancer clinical trials in Columbia, South Carolina
Here are the top 10 medical studies for lung cancer in Columbia, South Carolina
Popular filter options for lung-cancer columbia trials
Phase 3 Clinical Trials
View 84 phase 3 medical studies.
Checkpoint Inhibitor
Immunotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Charleston, South Carolina
This trial is testing whether Nivolumab, or a combination of Nivolumab and Ipilimumab, or Nivolumab and Platinum-Doublet Chemotherapy can help people with advanced lung cancer live longer without their disease getting worse, or improve overall survival.
Tyrosine Kinase Inhibitor
Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Clinical Trials With No Placebo
View 84 medical studies that do not have a placebo group.
Alkylating agents
Radiation + Chemotherapy for Advanced Lung Cancer
Recruiting1 awardPhase 2
Charlotte, North Carolina
This trial will test if a new cancer treatment is effective in treating locally-advanced NSCLC. The treatment involves radiation and chemotherapy, with or without additional consolidation chemotherapy. A total of 60 people will be enrolled over 4 years.
Anti-metabolites
Docetaxel +3 More for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Augusta, Georgia
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Behavioral Intervention
Gain-framed messaging +2 More for Smoking Cessation
Recruiting1 awardPhase 2
Charleston, South Carolina
This trial is testing a new way to help lung cancer patients quit smoking, by framed messaging and nicotine replacement therapy. If successful, this study could help many people quit smoking.
Checkpoint Inhibitor
Immunotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Charleston, South Carolina
This trial is testing whether Nivolumab, or a combination of Nivolumab and Ipilimumab, or Nivolumab and Platinum-Doublet Chemotherapy can help people with advanced lung cancer live longer without their disease getting worse, or improve overall survival.
View More Lung-cancer Columbia Trials
See another 69 medical studies focused on lung-cancer columbia.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.